These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16479829)

  • 21. Oncocytic adrenocortical carcinoma.
    Tanaka K; Kumano Y; Kanomata N; Takeda M; Hara I; Fujisawa M; Kawabata G; Kamidono S
    Urology; 2004 Aug; 64(2):376-7. PubMed ID: 15302503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy in a patient with adrenal carcinoma treated with mitotane: a case report and review of literature.
    Tripto-Shkolnik L; Blumenfeld Z; Bronshtein M; Salmon A; Jaffe A
    J Clin Endocrinol Metab; 2013 Feb; 98(2):443-7. PubMed ID: 23275528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies.
    Demeure MJ; Somberg LB
    Surg Oncol Clin N Am; 1998 Oct; 7(4):791-805. PubMed ID: 9735134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.
    Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H
    Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
    Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
    Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma.
    Seki M; Nomura K; Hirohara D; Kanazawa M; Sawada T; Takasaki K; Demura H
    Endocr Relat Cancer; 1999 Dec; 6(4):529-33. PubMed ID: 10730906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case report on metastasis surgery in adrenal cortex cancer].
    Buchholz NP; Süberli H; Ausfeld R
    Urologe A; 1992 Jan; 31(1):14-8. PubMed ID: 1553798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.
    Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
    Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical study and treatment results of adrenocortical carcinoma patients presented in Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore.
    Khan MS; Ali A; Tariq I; Khan MA; Bakar MA; Anwar AW
    J Pak Med Assoc; 2019 May; 69(5):717-719. PubMed ID: 31105294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical results of the use of mitotane for adrenocortical carcinoma.
    Kasperlik-Zaluska AA
    Braz J Med Biol Res; 2000 Oct; 33(10):1191-6. PubMed ID: 11004719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.
    Berruti A; Fassnacht M; Baudin E; Hammer G; Haak H; Leboulleux S; Skogseid B; Allolio B; Terzolo M
    J Clin Oncol; 2010 Aug; 28(23):e401-2; author reply e403. PubMed ID: 20567001
    [No Abstract]   [Full Text] [Related]  

  • 33. Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.
    Kornely E; Schlaghecke R
    Exp Clin Endocrinol; 1994; 102(1):50-3. PubMed ID: 8005209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term recurrence-free survival of adrenocortical cancer extending into the inferior vena cava and right atrium: Case report and literature review.
    Alghulayqah A; Alghasab N; Amin T; Alkahtani N; Farhat R; Alzahrani AS
    Medicine (Baltimore); 2017 May; 96(18):e6751. PubMed ID: 28471969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complete and lasting remission of a metastatic malignant adrenocortical carcinoma under treatment with OP'DDD alone].
    Remond S; Bardet S; Charbonnel B
    Presse Med; 1992 May; 21(18):865. PubMed ID: 1535153
    [No Abstract]   [Full Text] [Related]  

  • 36. Pregnancy in a patient with adrenocortical carcinoma during treatment with Mitotane - a case report.
    Baszko-Błaszyk D; Ochmańska K; Waśko R; Sowiński J
    Endokrynol Pol; 2011; 62(2):186-8. PubMed ID: 21528483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mitotane in the treatment of adrenal carcinoma].
    Sane T
    Duodecim; 2010; 126(17):2040-6. PubMed ID: 21053521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical treatment using mitotane for adrenocortical carcinoma.
    Terzolo M; Zaggia B; Allasino B; De Francia S
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):159-65. PubMed ID: 24732405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary management of adrenocortical carcinoma.
    Zini L; Porpiglia F; Fassnacht M
    Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
    Wahab NA; Zainudin S; AbAziz A; Mustafa N; Sukor N; Kamaruddin NA
    Arch Iran Med; 2016 Sep; 19(9):671-3. PubMed ID: 27631184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.